- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Fortis Healthcare to Raise Rs 1,500 Crore Through NCDs
New Delhi: Fortis Healthcare Ltd recently announced that its board has approved raising up to Rs 1,500 crore through the issuance of non-convertible debentures via private placement.
The company's board of directors at its meeting held on October 9, 2024, considered and approved issue of non-convertible debentures (NCDs) on a private placement basis to eligible investors, according to a regulatory filing.
In the filing, the healthcare company said that the eligible investors include but are not limited to identified anchor investors DBS Bank Ltd (DBS), The Hongkong and Shanghai Banking Corporation Ltd (HSBC), Citicorp Investment Bank (Singapore) Ltd., Mizuho Bank, Singapore and other foreign portfolio investors qualified during the bidding process.
The sum is planned to be raised through three series with DBS Bank Ltd as anchor investor for Series 1 for up to Rs 500 crore; HSBC through its GIFT FPI as anchor investor for Series 2 of up to Rs 500 crore; and Citicorp Investment Bank (Singapore) Ltd, Mizuho Bank, Singapore as anchor investors of Series 3 of Rs 500 crore.
The NCDs will have a tenure of 5 years from the date of allotment and are proposed to be listed on BSE, the company said.
Shares of Fortis Healthcare settled 1.73 per cent higher at Rs 607.40 per piece on the BSE.
Fortis Healthcare Ltdnon convertible debenturesNCDsDBS Bank LtdBanking Corporation LtdCiticorp Investment BankMizuho Bank
Source : PTIMeghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751
Next Story